LOGO
LOGO

Quick Facts

HOPE Therapeutics Says Intends To Acquire A Premier West Coast Interventional Psychiatric Clinic

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024

HOPE Therapeutics, Inc., an NRx Pharma (NRXP) daughter company, Thursday said it has signed a Letter of Intent (LOI) to acquire a premier West Coast interventional psychiatric clinic.

No financial terms of the deal have been disclosed.

Additionally, as part of the deal, the founder of the clinic, a pioneer and nationally recognized leader in the use of advanced treatments in central nervous system (CNS) disorders, has agreed to join HOPE as Chief Medical Innovation Officer (CMIO).

HOPE intends to establish the clinic to be acquired as a model for its net work of clinics across the country, providing treatment to patients suffering from problems such as suicidal depression, post-traumatic stress disorder (PTSD) and other CNS disorders. The treatment options include Ketamine, Spravatoâ, Transcranial Magnetic Stimulation (TMS), talk therapy among others. Additionally, patients may also have access to clinical trials of new treatment modalities through these clinics.

"This clinic is the ideal foundation for Hope's clinic network; the practice provides state-of-the-art treatment for patients dealing with many CNS disorders and has highly efficient operations; these aspects can serve as a model for future clinics entering our network," said Jonathan Javitt, and Matthew Duffy, Co-CEOs of HOPE. "Additionally, we look forward to working with the founder as our CMIO, as we establish HOPE as a model for clinics that aim to provide the latest standard of care treatments for CNS healthcare providers nationwide."

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update: April 13 – April 17, 2026

April 17, 2026 15:29 ET
The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.